Roivant Sciences (ROIV) Gross Margin Growth (5y) (2025 - 2026)
Powered by 
Analysis
Roivant Sciences (ROIV) Gross Margin Growth (5y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.55 Bn | 197.56 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.42 Bn | 178.24 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.44 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.90 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.63 Bn | 56.45 Bn | 1.37 Bn |
| 6 | Moderna | 54.26 Bn | 49.12 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.31 Bn | 31.00 Bn | 992.69 Mn |
| 8 | Biogen | 31.22 Bn | 29.93 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.23 Bn | 30.23 Bn | 1.16 Mn |
| 10 | Insmed | 28.16 Bn | 27.00 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,010.00 |
| Dec 31, 2025 | -492.00 |
| Sep 30, 2025 | 4,698.00 |
| Jun 30, 2025 | 432.00 |